US Stock Futures Signal Higher Start On Wall Street

Loading...
Loading...
Pre-open movers
US stock futures traded higher in early pre-market trade. Data on weekly jobless claims and the current account for the fourth quarter will be released at 8:30 a.m. ET. The general conditions index of the Philadelphia Fed's Business Outlook Survey for March and the Conference Board's index of leading indicators for February will be released at 10:00 a.m. ET. Futures for the Dow Jones Industrial Average jumped 89.50 points to 17,974.50, while the Standard & Poor's 500 index futures rose 7.45 points to 2,088.95. Futures for the Nasdaq 100 index rose 15.60 points to 4,437.60.
A Peek Into Global Markets
European markets were mostly higher today, with the Spanish Ibex Index rising 0.43%, STOXX Europe 600 Index falling 0.02% and German DAX 30 index rising 0.73%. French CAC 40 Index gained 0.22% and London's FTSE 100 Index rose 0.09%. In Asian markets, Japan's Nikkei Stock Average climbed 0.43%, Hong Kong's Hang Seng Index fell 0.38%, China's Shanghai Composite Index gained 0.98% and India's BSE Sensex slipped 0.73%.
Broker Recommendation
Analysts at Oppenheimer upgraded
Pier 1 Imports, Inc.PIR
from Market Perform to Outperform. The price target for Pier 1 Imports is set to $20.00. Pier 1 Imports shares rose 2.16% to $13.70 in pre-market trading.
Breaking news
  • Intercept Pharmaceuticals ICPT announced today new subgroup analyses from the Phase 2b FLINT trial of obeticholic acid (OCA) in patients with nonalcoholic steatohepatitis (NASH). To read the full news, click here.
  • Today Biogen Idec BIIB announced data from a pre-specified interim analysis of PRIME, the Phase 1b study of aducanumab (BIIB037), in which aducanumab demonstrated an acceptable safety profile and positive results on radiologic and clinical measurements in patients with prodromal or mild Alzheimer's disease (AD). To read the full news, click here.
  • Myriad Genetics MYGN today announced that results from the EMPATHY-P clinical study of Prolaris in patients newly diagnosed with prostate cancer will be highlighted at the 30th Annual Congress of the European Association of Urology. To read the full news, click here.
  • Shares of Darden Restaurants Inc. DRI surged more than 4% in pre-market trading after the company reported stronger-than-expected earnings for the third quarter. To read the full news, click here.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: NewsEurozoneFuturesGlobalPre-Market OutlookMarketsOppenheimerUS Stock Futures
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...